Literature DB >> 25790865

Determining the role of microRNAs in psychiatric disorders.

Orna Issler1, Alon Chen1.   

Abstract

Recent studies have revealed that patients with psychiatric disorders have altered microRNA (miRNA) expression profiles in the circulation and brain. Furthermore, animal studies have shown that manipulating the levels of particular miRNAs in the brain can alter behaviour. Here, we review recent studies in humans, animal models, cellular systems and bioinformatics that have advanced our understanding of the contribution of brain miRNAs to the regulation of behaviour in the context of psychiatric conditions. These studies highlight the potential of miRNA levels to be used in the diagnosis of psychiatric disorders and suggest that brain miRNAs could become novel treatment targets for psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25790865     DOI: 10.1038/nrn3879

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  103 in total

Review 1.  The Netrin-1/DCC Guidance Cue Pathway as a Molecular Target in Depression: Translational Evidence.

Authors:  Angélica Torres-Berrío; Giovanni Hernandez; Eric J Nestler; Cecilia Flores
Journal:  Biol Psychiatry       Date:  2020-05-11       Impact factor: 13.382

Review 2.  Intergenerational Transmission of Stress in Humans.

Authors:  Mallory E Bowers; Rachel Yehuda
Journal:  Neuropsychopharmacology       Date:  2015-08-17       Impact factor: 7.853

Review 3.  DNA methylation correlates of PTSD: Recent findings and technical challenges.

Authors:  Filomene G Morrison; Mark W Miller; Mark W Logue; Michele Assef; Erika J Wolf
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-11-30       Impact factor: 5.067

Review 4.  Neurobiology of Resilience: Interface Between Mind and Body.

Authors:  Flurin Cathomas; James W Murrough; Eric J Nestler; Ming-Hu Han; Scott J Russo
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

5.  Brain microRNAs associated with late-life depressive symptoms are also associated with cognitive trajectory and dementia.

Authors:  Thomas S Wingo; Jingjing Yang; Wen Fan; Se Min Canon; Ekaterina Sergeevna Gerasimov; Adriana Lori; Benjamin Logsdon; Bing Yao; Nicholas T Seyfried; James J Lah; Allan I Levey; Patricia A Boyle; Julia A Schneider; Philip L De Jager; David A Bennett; Aliza P Wingo
Journal:  NPJ Genom Med       Date:  2020-02-06       Impact factor: 8.617

Review 6.  Current Knowledge on Gene-Environment Interactions in Personality Disorders: an Update.

Authors:  Andrea Bulbena-Cabre; Anahita Bassir Nia; M Mercedes Perez-Rodriguez
Journal:  Curr Psychiatry Rep       Date:  2018-08-09       Impact factor: 5.285

Review 7.  Searching for convergent pathways in autism spectrum disorders: insights from human brain transcriptome studies.

Authors:  Akira Gokoolparsadh; Gavin J Sutton; Alexiy Charamko; Nicole F Oldham Green; Christopher J Pardy; Irina Voineagu
Journal:  Cell Mol Life Sci       Date:  2016-07-12       Impact factor: 9.261

8.  MicroRNA-34a Regulates the Depression-like Behavior in Mice by Modulating the Expression of Target Genes in the Dorsal Raphè.

Authors:  Luisa Lo Iacono; Donald Ielpo; Alessandra Accoto; Matteo Di Segni; Lucy Babicola; Sebastian Luca D'Addario; Fabio Ferlazzo; Tiziana Pascucci; Rossella Ventura; Diego Andolina
Journal:  Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.590

Review 9.  Turing Revisited: Decoding the microRNA Messages in Brain Extracellular Vesicles for Early Detection of Neurodevelopmental Disorders.

Authors:  Virginie Gillet; Darel John Hunting; Larissa Takser
Journal:  Curr Environ Health Rep       Date:  2016-09

Review 10.  The Role of MicroRNAs in Environmental Risk Factors, Noise-Induced Hearing Loss, and Mental Stress.

Authors:  Verónica Miguel; Julia Yue Cui; Lidia Daimiel; Cristina Espinosa-Díez; Carlos Fernández-Hernando; Terrance J Kavanagh; Santiago Lamas
Journal:  Antioxid Redox Signal       Date:  2017-06-30       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.